NOVERA COMPOUNDS

GHRP-6 10mg

Coming soon
Purity Guarantee

GHRP-6 10mg

Sign in to view pricing and purchase this product.

Log In Sign Up

Coming Soon

This peptide will be available soon.

Quantity Discount (%) Price
1 - 5 — $55.00
6 - 10 9.09 % $50.00
11 - 20 18.18 % $45.00
21+ 25.45 % $41.00

Why choose Novera Compounds peptides

Research-grade Quality

Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.

Documented and traceable

  • Batch number on every vial

  • Published Certificates of Analysis

  • Purity verified by third-party testing

Handled and shipped with care

Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.

About the product

GHRP-6 (10mg) is a synthetic hexapeptide developed for laboratory investigation into hormone-related signaling and metabolic activity. Known as growth hormone-releasing peptide 6, this compound is composed of six amino acids and has a molecular weight of approximately 873.03 g/mol. It is typically supplied as a purified lyophilized powder in a sealed vial for controlled research preparation.

In scientific settings, research on GHRP-6 has explored how this peptide interacts with biological systems involved in cellular communication and endocrine signaling. The compound is produced to research-grade purity standards and is commonly used in experimental models focused on peptide-driven signaling processes.

GHRP-6 (10mg) Key Features & Specs

  • Subcategory: Muscle Growth & Performance Peptides
  • Strength: 10 mg
  • CAS: 87616-84-0
  • Chemical Formula: C₄₆H₅₆N₁₂O₆
  • Molecular Weight: 873.03 g/mol
  • Peptide Sequence: His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂
  • Synonyms: GHRP-6, Growth Hormone Releasing Peptide-6

For laboratory research use only.

GHRP-6 (10mg) Research Uses

In laboratory settings, GHRP-6 is being researched for its role in regulating hormone signaling and metabolic balance. Studies of GHRP-6 focus on how this peptide interacts with cellular communication pathways linked to endocrine function.

Researchers examine how GHRP-6 may influence biological systems associated with metabolism, appetite regulation, and cellular signaling. These studies are conducted in controlled environments, such as cell cultures or preclinical models.

The peptide is also being investigated for its interactions with signaling pathways that influence energy balance and cellular responses in hormone-related systems.

GHRP-6 (10mg) Insights & Observed Findings

Experimental investigations have evaluated GHRP-6 under controlled laboratory conditions, using various concentrations to observe receptor activation and cellular responses. Many studies focus on how peptide exposure affects intracellular signaling, including measurable changes in pathways associated with hormone signaling.

Published findings describe the use of GHRP-6 in in vitro and preclinical models, in which researchers monitor outcomes such as calcium mobilization, changes in gene expression, and signaling pathway activity. These observations help clarify how peptide–receptor interactions contribute to broader biological processes.

The collected data continue to support ongoing scientific understanding of how peptide compounds interact with endocrine and metabolic systems in controlled research settings.

GHRP-6 (10mg) Handling & Storage

GHRP-6 should be handled according to standard laboratory procedures for peptide-based compounds. The lyophilized material is typically stored at approximately –20°C and protected from light and moisture prior to preparation.

Researchers should allow the vial to reach room temperature before opening to reduce the risk of condensation. Once reconstituted, the solution should be prepared using sterile techniques and stored under refrigerated conditions for laboratory use.

To maintain sample integrity, it is recommended to avoid repeated freeze-thaw cycles and follow established peptide-handling protocols throughout GHRP-6 research.

Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.

References

  1. de Sá LB, Nascif SO, Correa-Silva SR, et al. Effects of ghrelin, growth hormone-releasing peptide-6, and growth hormone-releasing hormone on growth hormone, adrenocorticotropic hormone, and cortisol release in type 1 diabetes mellitus. Metabolism. 2010;59(10):1536-1542. doi:10.1016/j.metabol.2010.01.021
  2. Catalina PF, Mallo F, Andrade MA, García-Mayor RV, Diéguez C. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. J Clin Endocrinol Metab. 1998;83(10):3663-3667. doi:10.1210/jcem.83.10.5153
  3. Cabrales A, Gil J, Fernández E, et al. Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers. Eur J Pharm Sci. 2013;48(1-2):40-46. doi:10.1016/j.ejps.2012.10.006
  4. Oliveira JH, Vieira JG, Abucham J, Lengyel AM. GHRP-6 is able to stimulate cortisol and ACTH release in patients with Cushing's disease: comparison with DDAVP. J Endocrinol Invest. 2003;26(3):230-235. doi:10.1007/BF03345162